Tacrolimus Capsules, USP, 0.5 mg, 100 capsules/bottle, Rx only, Manufactured in India by Sandoz Private ltd. for Sandoz Inc., Princeton, NJ NDC 0781-2102-01
Published January 1, 2014 · Recall initiated: October 22, 2013
Summary
FDA records drug Class II recall D-383-2014, published January 1, 2014 and initiated October 22, 2013. Recalling firm: Sandoz Incorporated; Status: Terminated; Reported quantity: 12,521 bottles; Lot: Lots DE9898, DE9900, DE9903, DE9908, DE9911. Exp. 06/14. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Cross Contamination with Other Products: findings of carryover of trace amounts of a previously manufactured product fluvastatin
What to do
Voluntary: Firm initiated · Letter
Get an email if TACROLIMUS has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- TACROLIMUS
- Manufacturer
- Sandoz Incorporated
- Distributor
- Nationwide
- UPC
- 0307812103012
- Lot
- Lots DE9898, DE9900, DE9903, DE9908, DE9911. Exp. 06/14
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATacrolimus Capsules, USP 1mg, 100-Count Bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories Limited,January 17, 2024
- FDATacrolimus Capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Mfd. by Dr. Reddy's Laboratories Limited,March 1, 2023
- FDATacrolimus Ointment, 0.1%, For Dermatological Use Only, Not for Ophthalmic Use, Rx Only, a) 30 g tube, NDCAugust 10, 2022
- FDATacrolimus Capsules, USP 5mg, 100-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDCApril 1, 2020
- FDAQnasl (beclomethasone dipropionate) Nasal Aerosol, 80 mcg per spray, 120 metered sprays, 8.7 g inhaler, RxJanuary 1, 2014
- FDAPhenylephrine Nasal 1% Spray, 480 mL bottles, For Office Use, Tower Pharmacy, 26732 Crown Valley Pkwy, SuiteJanuary 1, 2014
Questions about this recall
Was Tacrolimus Capsules, USP, 0.5 mg, 100 capsules/bottle, Rx only, Manufactured in India by Sandoz Private ltd. for Sandoz Inc., Princeton, NJ NDC 0781-2102-01 recalled?
Yes. FDA published recall D-383-2014 on January 1, 2014. Reported hazard: Cross Contamination with Other Products: findings of carryover of trace amounts of a previously manufactured product fluvastatin
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: TACROLIMUS. UPC: 0307812103012.